Archive · 11 Nov 2025
Neuberg Diagnostics Plans $350 Million IPO for 2026 Listing
A company called Neuberg Diagnostics, which tests samples for people to find out about their health, is planning to become a public company.
This means they want to sell small pieces of their company, called stocks, to lots of people.
They hope to raise about $350 million, which is a lot of money, by doing this.
They want to do this in 2026.
Neuberg is based in India, which is a country where many companies are starting to sell stocks to the public.
The company tests for many things, including genetic testing and rare diseases.
Neuberg's founder also has other health companies that he might make public later.
The money raised will help Neuberg grow and get better at what they do.
Neuberg Diagnostics is reportedly planning an IPO to raise approximately $350 million.
The company aims for a listing in 2026 and is in discussions with investment bankers.
The IPO would tap into India's strong market for initial public offerings and a growing diagnostics sector.
Neuberg Diagnostics, founded in 2017, operates in over 250 Indian cities, UAE, US, and South Africa.
The company recently raised 9.4 billion rupees to enhance capabilities and expand its footprint.
- Who
- Neuberg Diagnostics Pvt., an Indian clinical laboratory-testing chain.
- What
- Planning an initial public offering (IPO) aiming to raise approximately $350 million.
- When
- Aiming for a listing in 2026.
- Where
- India
- Why
- To capitalize on the growing Indian diagnostics market and the country's hot IPO market.
- Company Name
- Neuberg Diagnostics Pvt.
- IPO Target Amount
- $350 million
- Target Listing Year
- 2026
- Headquarters
- Chennai, India
- Founding Year
- 2017
- Global Presence
- India, UAE, US, South Africa
- Recent Funding
- 9.4 billion rupees earlier this year